Lux Health Tech Acquisition Corp. (Nasdaq: LUXA) is a blank-check company that registered its initial public offering via an S-1 filing submitted to the SEC on October 9, 2020, under accession number 0001564590-20-046221. The vehicle was sponsored by an affiliate of Lux Capital Management, the New York- and Menlo Park-based venture firm known for backing science and deep-technology companies. LUXA was formed to pursue a business combination in the health technology sector, targeting opportunities at the intersection of technology and healthcare services or life sciences. The SPAC completed its IPO in the fourth quarter of 2020, part of a record wave of blank-check issuances that year. Visit SpacDesk and sign up for full data on LUXA, including deal timelines, SEC filings, and comparable transactions.